The aim of the study was to assess of the effect of subdiaphragmatic vagotomy on lipid profile and insulin resistance in diabetic obese rat model. Fifty Male Albino rats 200±50g were divided into 5 groups 10 per each. Subdiaphragmatic vagotomy and sham operations were applied on diabetic obese rat model induced by high fat diet for 5 weeks and low dose of streptozotocin (30mg/kg). After 5 weeks, serum samples were collected for confirmation of hyperlipidemia and lee obesity index was measured. At the end of the experiment, oral glucose tolerance test, lee obesity index, lipid profile, fasting insulinemia, fasting glucose, insulin resistance (HOMA-IR) and histopathology of pancreases were assessed. Results revealed that Subdiaphragmatic vagotomy significantly improved hyperlipidemia as it normalized plasma triglyceride level, decreased plasma cholesterol level and increased plasma high density lipoprotein level in diabetic and non-diabetic obese vagotomized rats.
Introduction
Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia as result of insulin resistance and a relative deficiency of insulin (1) . More than 90% from all patients with DM have type 2 diabetes mellitus (T2DM) and the majority of them are obese (2) .
The prevalence of T2DM in Egypt was around 15.6% of all adults in 2015 (3) . Currently, the most effective methods of T2DM treatment are insulin, oral antidiabetic drugs, lifestyle changes and surgical procedures such as Roux-en-Y gastric bypass (RYGB) (2) . Unfortunately, current medical treatment has been relatively unsatisfied as more than half of the patients cannot achieve the therapeutic goal (4) . 
Induction of experimental hyperlipidemia in rats:
Rats in the group III, IV, V were given HFD (40 % fat, 42 % carbohydrate, 18 % protein) as a total percentage of calories for 5 weeks (15,16).The rats were considered hyperlipidemic when there was significant increase in the plasma lipid profile when compared with the control group (17, 18) .
After 5 weeks, the Lee obesity index of rats in the HFD group was calculated by dividing the cube root of BW (g) by nasoanal length (cm) and multiplying the result by 1000, and rats with lee obesity index greater than 310 were considered obese (17, 19) .
Induction of diabetes mellitus:
At 6 th week, 12 hours fasting, the rats were given a single intraperitoneal injection of STZ (sigma-Aldrich, USA catalog No: 130, supplied in powder form) in a dose of 30 mg/kg to induce DM (15, 16) . During the first 24 hours after the STZ intraperitoneal injection, rats were given 5% glucose solution.
After 72 hours, rats with blood glucose levels more than or equal 200 mg/dl (11.1mmol/ L) were considered diabetic rats and were assigned to the study (15, 20) . were separated from the esophagus and cut off (19, 21) . After the operation, rats were received systemic analgesic (Ibuprofen 5mg/kg SC) for 3 days in order to decrease postoperative pain (22) and subcutaneous 10 cm glucose 5% (Figure 1 ).
Sham operation:
Rats were subjected to the same surgical procedures of vagotomy, but the vagus nerve wasn't cut off.
Oral glucose tolerance test (OGTT): Eight weeks
after vagotomy, a blood sample was taken from the tail tip after 12 hours of fasting, to obtain fasting blood glucose level (time 0) using a glucometer (OK-1 meter, Biotech CO, Ltd). Then, all rats were given oral gavage of glucose in dose of 2 g/kg , and blood glucose levels at 15, 30, 60, 120 min after gavage were measured by glucometer from tail tip blood (20, 21) . 
At the end of the study (8 weeks after vagotomy):
Rats were euthanized with a combination of 100 mg/kg of ketamine and 10 mg/kg of xylazine (16) .
Then, blood samples were taken by heart puncture for insulin measurement by ELISA (RayBio®, USA, Catalog No: ELR-Insulin) according to the manufacturer's instructions and lipid profile (CHOL, TG, HDL and LDL) by an automatic biochemistry analyzer. After sacrification, the retroperitoneal and perigonadal fat pads from all groups of rats were removed and weighed for assessment of obesity. The stomach food retention from all operated groups were assessed by the ratio between the stomach weight per body weight to confirm vagotomy (19, 21) .
Statistical analysis:
Data were reported as mean ±SD and were analyzed with SPSS statistical software version 20.
One way ANOVA was used for comparing means of a variable in the five groups.
Results

Body weight, lee obesity index and perigonadal and retroperitoneal fat pads weight results:
Subdiaphragmatic vagotomy decreased BW, lee obesity index and perigonadal fat pads weight in diabetic and non-diabetic obese vagotomized rats.
The BW progression in HFD fed groups was significantly higher than control groups after 5 weeks of HFD (p value >0.0001). The BW of diabetic and non-diabetic obese vagotomized groups was significantly lower than of diabetic obese sham group at the end of experiment (p value >0.0001; Table 1 ).
Stomach weight (g) / BW (g) ratio to confirm subdiaphragmatic vagotomy
All vagotomized groups presented with higher stomach weight/ BW ratios than sham groups (Table 1) . 
Histopathology of pancreses:
Diabetic obese sham group revealed showed shrinkage of islets of Langerhans and fatty infiltration of exocrine portion. Restoration of the pancreatic islet structure was restored afer subdiaphragmatic vagotomy, (Figure 6,7,8) . 
